Insomnia
Conditions
Interventions
Experimental Group:Received 7.5 mg zopiclone tablets per night
Combined the repeated transcranial magnetic stimulation (rTMS),this was done once a day for a total of 10 days
After enrollment and 10 days of treatment, the pittsburgh sleep quality Index (PSQI )scale, the hamilton depression rating scale 24-item(HAMD-24) scale, the hamilton anxiety scale 14-item(HAMA-14) sca
Control Group:Received 7.5 mg zopiclone tablets per night
Give pseudo-stimulation ,this was done once a day for a total of 10 days
Sponsors
Affiliated Kangning Hospital of Ningbo University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. meet the diagnostic criteria for chronic insomnia of the International Classification of Disorders (ICD-10 ); 2 .age 18-60 years; 3.Hamilton Depression Rating Scale 24-item (HAMD-24) <=8 , Hamilton Anxiety Scale 14-item (HAMA-14)<=7.
Exclusion criteria
Exclusion criteria: 1. No serious organic disease, alcohol or drug dependence; 2.Rules out bipolar disorder, anxiety disorder, obsessive-compulsive disorder, post-traumatic stress, restless leg syndrome, rapid eye movement sleep behavior abnormalities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The data of Montreal Cognitive Assessment(MoCA);Total sleep time (TST);Rapid Eye Movement sleep latency;Percentage of Rapid Eye Movement sleep (REM%);Rapid Eye Movement sleep architecture;Percentage of stage 3 sleep (N3%);Percentage of Wake After Sleep Onset(WASO%); | — |
Secondary
| Measure | Time frame |
|---|---|
| The data of Pittsburgh Sleep Quality Index(PSQI);The data of Hamilton Depression Rating Scale 24-item(HAMD-24) ;The data ofHamilton Anxiety Scale 14-item(HAMA-14); | — |
Countries
China
Contacts
Public ContactYongchong Wang
Affiliated Kangning Hospital of Ningbo University
Outcome results
None listed